Reference Materials are not therapeutics and we do not sell to patients
While Semaglutide and Tirzepatide are FDA-approved for specific conditions (such as Type 2 Diabetes or chronic weight management), their use for PCOS is often considered "off-label" and should be managed strictly under clinical supervision
It has been studied for protection of the liver from toxic damage (alcohol, antibiotics, etc.)
Adults aged 18 years and over
Drug Interactions: May interact with anticoagulants, blood pressure medications, and other supplements
Eli Lilly will partner with Nimbus Therapeutics to develop an oral treatment for obesity and other metabolic diseases, through a multi-year research collaboration and exclusive, worldwide license agreement that could generate more than $1.3 billion for the Boston artificial intelligence (AI)-based drug developer